Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 4, 2020Journal of Microbiology Immunology and InfectionOpen Access

Treatment options for COVID-19: The reality and challenges

View Full Paper
Ask AI
Bookmark
Share

Authors

SJShio‐Shin JeanMin Sheng General HospitalPLPing‐Ing LeeNational Taiwan University HospitalPHPo‐Ren HsuehFu Jen Catholic University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jean et al. (2020) studied this question.

synapsesocial.com/papers/6a1115bb6f378c85fcf349dbhttps://doi.org/10.1016/j.jmii.2020.03.034
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Imbalance Between Pulmonary Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Activity in Acute Respiratory Distress Syndrome2013 · 60 citations
  2. 2Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses2015 · 291 citations
  3. 3Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients2019 · 24 citations
  4. 4Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV2020 · 1,817 citations
  5. 52019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China2020 · 91 citations